A trial reports that a five-session radiotherapy approach for prostate cancer achieves outcomes comparable to surgery while causing fewer major side effects. The treatment is described as “non-invasive,” using radiotherapy rather than an operation.
The reporting emphasizes potential reductions in common complications associated with prostate surgery, particularly urinary and sexual side effects. In the coverage provided, both outlets focus on the prospect that many men could avoid debilitating functional impacts if the radiotherapy regimen delivers similar cancer control to surgical treatment. The articles do not provide additional details here on study design, patient selection, endpoints, or statistical comparisons, so specific measures of effectiveness and the magnitude of side-effect differences are not included in the supplied text.
Overall, the emphasis across sources is on balancing cancer treatment effectiveness with quality-of-life outcomes, presenting the radiotherapy option as an alternative to surgery.
